Change over period: —
NSE · LINDEINDIA
LINDEINDIA
-12.5% from the 52-week high · +21.9% above the low
Linde India Ltd. engages in the manufacture and distribution of industrial gases. The company is headquartered in Kolkata, West Bengal and currently employs 207 full-time employees. The firm operates through two segments: Gases and Related Products and Project Engineering Division (PED). The Gases and Related Products segment comprises pipeline gas supplies (Onsite) to industrial customers mainly in the primary steel, glass and chemical industries, and supply of liquefied gases through cryogenic tankers (Bulk) to cater to mid-size demands across a range of industrial sectors and compressed gas supply in cylinders (Packaged Gas) for meeting smaller demand for gases mainly across fabrication, manufacturing and construction industry. PED comprises the business of designing, supplying, installing and commissioning tonnage air separation units (ASU) of medium to large size, and projects relating to setting up of nitrogen plants, pressure swing adsorption (PSA) plants and gas distribution systems. PED also manufactures cryogenic vessels for in-house use, as well as for sale to third-party customers.
The short version. LINDEINDIA reported revenue of ₹723 crore for Sep 2026, up 12.3% from a year earlier. Net profit was ₹119 crore (down 30.4% year on year). Return on equity was 12.9% in Mar 2026. Promoter holding was 75.0% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
LINDEINDIA trades 12.5% below its 52-week high and 21.9% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹723 cr.
Sep 2026 net profit of ₹119 cr.
10.1 pts lower than a year earlier.
Revenue compounded at -0.5% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 723 | 694 | 614 | 701 | 644 | 571 | 592 | 606 |
| Net profit | 119 | 105 | 77 | 193 | 171 | 107 | 118 | 116 |
| Net margin % | 16.4 | 15.1 | 12.6 | 27.6 | 26.5 | 18.8 | 20.0 | 19.2 |
| EPS (₹) | 13.93 | 12.26 | 9.08 | 22.67 | 20.05 | 12.57 | 13.88 | 13.64 |
Annual
| FY2026 | FY2025 | FY2024 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | 2531 | 2485 | 2769 | 2505 | 2112 | 1471 | 1762 |
| Net profit | 549 | 455 | 434 | 439 | 507 | 151 | 727 |
| Net margin % | 21.7 | 18.3 | 15.7 | 17.5 | 24.0 | 10.3 | 41.3 |
| EPS (₹) | 64.37 | 53.33 | 50.9 | 51.45 | 59.47 | 17.72 | 85.27 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 12.9% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Dec 2022 | |
|---|---|---|---|---|
| Return on equity % | 12.9 | 11.9 | 12.5 | 14.4 |
| Return on capital % | 15.1 | 15.0 | 15.3 | 14.0 |
| EBITDA margin % | 36.4 | 32.6 | 27.4 | 25.5 |
| Net margin % | 21.5 | 17.8 | 15.2 | 17.0 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -0.5% | 11.1% |
| Profit CAGR | 7.8% | 29.4% |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.15 pts over 8 quarters.
Down 0.07 pts over 8 quarters.
+31 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 75.0 | 0.0 |
| FII | 2.27 | 2.63 | 2.51 | 2.35 | 2.04 | 2.05 | 2.04 | 2.12 | -0.15 |
| DII | 6.81 | 6.49 | 6.62 | 6.75 | 6.94 | 6.88 | 6.79 | 6.74 | -0.07 |
| Public | 15.92 | 15.89 | 15.87 | 15.89 | 16.02 | 16.07 | 16.17 | 16.13 | +0.21 |
Mutual fund holdings · Oct 2026
133 schemes hold this stock
102 the month before.
- Taurus Mid Cap Fund4.61% of NAV
- Baroda BNP Paribas Innovation Fund3.71% of NAV
- Kotak Nifty Chemicals ETF3.6% of NAV
- Groww Nifty Chemicals ETF3.6% of NAV
- Invesco India Nifty Chemical Index Fund3.53% of NAV
- Invesco India Infrastructure Fund3.38% of NAV
- quant Mid Cap Fund3.25% of NAV
- Kotak ESG Exclusionary Strategy Fund3.0% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for LINDEINDIA are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about LINDEINDIA
What is the LINDEINDIA share price?
LINDEINDIA (LINDEINDIA) last closed at ₹6,771.00, down 1.37% on the day. Its 52-week range is ₹5,632.50 to ₹7,847.50.
What is the market cap of LINDEINDIA?
LINDEINDIA has a market capitalisation of about ₹58,580 crore. Its price-to-earnings ratio is 117.8.
How are LINDEINDIA's latest results?
LINDEINDIA reported revenue of ₹723 crore for Sep 2026, up 12.3% from a year earlier. Net profit was ₹119 crore (down 30.4% year on year). Return on equity was 12.9% in Mar 2026. Promoter holding was 75.0% in Sep 2026, up 0.00 points over 8 quarters.
Who owns LINDEINDIA?
As of Sep 2026, shareholding was: Promoter 75.0%, FII 2.12%, DII 6.74%, Public 16.13%.
How many mutual funds hold LINDEINDIA?
133 mutual fund schemes held LINDEINDIA in October 2026. That compares with 102 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 07 Aug 2025 · Final Dividend - Rs. 4.5
- 07 Aug 2025 · Special Dividend - Rs. 7.5
- 05 Aug 2024 · Final Dividend - Rs. 4
- 05 Aug 2024 · Special Dividend - Rs. 8
- 10 Aug 2023 · Final Dividend - Rs. 4.5
- 10 Aug 2023 · Special Dividend - Rs. 7.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.